Covance, Inc. (NYSE:CVD)

CAPS Rating: 4 out of 5

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Recs

0
Player Avatar pjani06 (45.90) Submitted: 10/31/2008 8:51:15 PM : Outperform Start Price: $50.02 CVD Score: -46.84

Worldwide drug development needed - great entry point & 71-0 outperform calls by caps all stars

Featured Broker Partners


Advertisement